Multidrug resistance reversal activity of permethyl ningalin B amide derivatives

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

A series of amide derivatives of permethyl ningalin B were prepared and examined as multidrug resistance (MDR) reversal agents illustrating that the C5 carboxylate is widely tolerant of such derivatization.

Knowledge Graph

Similar Paper

Multidrug resistance reversal activity of permethyl ningalin B amide derivatives
Bioorganic & Medicinal Chemistry Letters 2004.0
Multidrug resistance reversal activity of key ningalin analogues
Bioorganic & Medicinal Chemistry Letters 2003.0
Optimization of permethyl ningalin B analogs as P-glycoprotein inhibitors
Bioorganic & Medicinal Chemistry 2015.0
Design and Syntheses of Permethyl Ningalin B Analogues: Potent Multidrug Resistance (MDR) Reversal Agents of Cancer Cells
Journal of Medicinal Chemistry 2010.0
Synthesis and structure–activity relationships of sinenxan A derivatives as multidrug resistance reversal agents
Bioorganic & Medicinal Chemistry Letters 2010.0
Structure–Activity Relationship Study of Permethyl Ningalin B Analogues as P-Glycoprotein Chemosensitizers
Journal of Medicinal Chemistry 2013.0
Extending the structure−activity relationship study of marine natural ningalin B analogues as P-glycoprotein inhibitors
European Journal of Medicinal Chemistry 2017.0
1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: A novel series of highly potent revertants of P-glycoprotein associated multidrug resistance
Bioorganic & Medicinal Chemistry Letters 2008.0
Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance
Journal of Medicinal Chemistry 2017.0
Papyriferic acid derivatives as reversal agents of multidrug resistance in cancer cells
Bioorganic & Medicinal Chemistry 2010.0